3.2. Analysis.
Comparison 3 Pembrolizumab versus chemotherapy (post‐hoc included subgroup analyses), Outcome 2 Overall survival based on sex.
Comparison 3 Pembrolizumab versus chemotherapy (post‐hoc included subgroup analyses), Outcome 2 Overall survival based on sex.